New Year Update from Santhera

Santhera Pharmaceuticals has written their first Duchenne Community letter of 2020 providing updated information about SIDEROS. This clinical trial is the largest ever to study respiratory function in DMD and is open to boys 10 or older regardless of ambulatory status and genetic mutation.

Please contact sideros@santhera.com to be connected with the trial site, read their letter to learn of more details on eligibility criteria, and talk to your doctor to get screened for the trial.

You can read the full letter here.